Literature DB >> 6378234

The dose-response characteristics of the acute non-diuretic peripheral vascular effects of frusemide in normal subjects.

G D Johnston, D P Nicholls, W J Leahey.   

Abstract

The peripheral venous and arterial effects of frusemide, plasma renin activity and plasma frusemide concentrations were examined during the 15 min period following the i.v. administration of 0, 5, 10, 20, 40 and 80 mg of frusemide in a group of nine salt depleted volunteers. The responses to 80 mg frusemide given orally during the 1 1 h period after administration were also examined. Increases in venous capacitance 5 min after administration of 5 and 10 mg frusemide were observed (P less than 0.05) but no significant increases were apparent after the higher doses. At 10 min, the increases in venous capacitance showed a flat dose response effect with significant increases throughout the dose range (5-80 mg). Decreases in forearm blood flow occurred at 5 and 10 min after frusemide administration at all the doses studied (P less than 0.05) while blood pressure responses at 10 min showed increasing effect with increasing dose. An oral dose of 80 mg frusemide produced a rise in venous capacitance 15 min after administration and a decrease in forearm blood flow during the period 15-60 min without any alteration in heart rate or blood pressure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378234      PMCID: PMC1463584          DOI: 10.1111/j.1365-2125.1984.tb05024.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Comparison of direct effects of angiotensin and other vasoactive agents on small and large blood vessels in several vascular beds.

Authors:  F J HADDY; J I MOLNAR; C W BORDEN; E C TEXTER
Journal:  Circulation       Date:  1962-01       Impact factor: 29.690

2.  Determinants of response to frusemide in normal subjects.

Authors:  R A Branch; C J Roberts; M Homeida; D Levine
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  A random-zero sphygmomanometer.

Authors:  B M Wright; C F Dore
Journal:  Lancet       Date:  1970-02-14       Impact factor: 79.321

5.  Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.

Authors:  K Dikshit; J K Vyden; J S Forrester; K Chatterjee; R Prakash; H J Swan
Journal:  N Engl J Med       Date:  1973-05-24       Impact factor: 91.245

6.  High-performance liquid chromatographic assays for furosemide in plasma and urine.

Authors:  E T Lin; D E Smith; L Z Benet; B A Hoener
Journal:  J Chromatogr       Date:  1979-07-21

7.  Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.

Authors:  C S Liang; H Gavras; W B Hood
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

Review 8.  Prostaglandins and local circulatory control.

Authors:  E J Messina; R Weiner; G Kaley
Journal:  Fed Proc       Date:  1976-10

9.  Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins.

Authors:  G D Johnston; W R Hiatt; A S Nies; N A Payne; R C Murphy; J G Gerber
Journal:  Circ Res       Date:  1983-11       Impact factor: 17.367

10.  The effects of captopril on the acute vascular responses to frusemide in man.

Authors:  G D Johnston; D P Nicholls; W J Leahey; M B Finch
Journal:  Clin Sci (Lond)       Date:  1983-10       Impact factor: 6.124

View more
  10 in total

Review 1.  The acute vascular effects of frusemide in heart failure.

Authors:  P S Jhund; J J McMurray; A P Davie
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

Review 2.  Allopathy--the therapeutic legacy.

Authors:  G D Johnston
Journal:  Ir J Med Sci       Date:  1989-01       Impact factor: 1.568

Review 3.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

4.  Comparison of the acute vascular effects of frusemide and bumetanide.

Authors:  G D Johnston; D P Nicholls; G B Kondowe; M B Finch
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

Review 5.  Haemodynamic effects of diuretics in heart failure.

Authors:  E B Raftery
Journal:  Br Heart J       Date:  1994-08

6.  Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.

Authors:  T M MacDonald; K Craig; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

7.  The effect of nitric oxide inhibition on the renin response to frusemide, in man.

Authors:  A F Lee; D G Kiely; W J Coutie; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

8.  Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man.

Authors:  R J MacFadyen; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

9.  Mechanisms of renal vasoconstriction following furosemide in conscious rats.

Authors:  B J Janssen; P H Eerdmans; J F Smits
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

Review 10.  Rational use of diuretics in acute decompensated heart failure.

Authors:  Jason A Goebel; Adrian B Van Bakel
Journal:  Curr Heart Fail Rep       Date:  2008-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.